Skip to main content
Top
Published in: Internal and Emergency Medicine 8/2018

01-12-2018 | THE CUTTING EDGE: RESEARCH UPDATE

Fluid intake and chronic kidney disease: effect of coaching an increase in fluid intake on kidney function decline

Authors: Viviana Bozzano, Elena Abati, Gruppo di Autoformazione Metodologica (GrAM)

Published in: Internal and Emergency Medicine | Issue 8/2018

Login to get access

Excerpt

Despite the commonly held view that drinking more water is beneficial to kidney function, little scientific data exist that support this belief. In observational studies, increased water intake is associated with a mortality reduction or with a reduced risk of developing chronic kidney disease (CKD) in the general population [13]. In animal models of CKD who underwent nearly complete bilateral nephrectomy, it is observed that an increased water consumption suppresses plasmatic antidiuretic hormone (ADH) concentration, reduces levels of copeptin [4] and improves kidney function [5]. However, the effects of hyperhydration on kidney function of human patients with CKD have not yet been elucidated. …
Literature
1.
go back to reference Clark WF, Sontrop JM, Macnab JJ et al (2011) Urine volume and change in estimated GFR in a community-based cohort study. Clin J Am Soc Nephrol 6:2634–2641CrossRef Clark WF, Sontrop JM, Macnab JJ et al (2011) Urine volume and change in estimated GFR in a community-based cohort study. Clin J Am Soc Nephrol 6:2634–2641CrossRef
2.
go back to reference Strippoli GFM, Craig JC, Rochtchina E et al (2011) Fluid and nutrient intake and risk of chronic kidney disease. Nephrology 16:326–334CrossRef Strippoli GFM, Craig JC, Rochtchina E et al (2011) Fluid and nutrient intake and risk of chronic kidney disease. Nephrology 16:326–334CrossRef
3.
go back to reference Sontrop JM, Dixon SN, Garg AX et al (2013) Association between water intake, chronic kidney disease, and cardiovascular disease: a cross-sectional analysis of NHANES data. Am J Nephrol 37:434–442CrossRef Sontrop JM, Dixon SN, Garg AX et al (2013) Association between water intake, chronic kidney disease, and cardiovascular disease: a cross-sectional analysis of NHANES data. Am J Nephrol 37:434–442CrossRef
4.
go back to reference Sontrop JM, Huang SH, Garg AX et al (2005) Effect of increased water intake on plasma copeptin in patients with chronic kidney disease: results from a pilot randomised controlled trial. BMJ Open 5(11):e008634CrossRef Sontrop JM, Huang SH, Garg AX et al (2005) Effect of increased water intake on plasma copeptin in patients with chronic kidney disease: results from a pilot randomised controlled trial. BMJ Open 5(11):e008634CrossRef
5.
go back to reference Clark WF, Sontrop JM, Huang SH et al (2016) Hydration and chronic kidney disease progression: a critical review of the evidence. Am J Nephrol 43:281–292CrossRef Clark WF, Sontrop JM, Huang SH et al (2016) Hydration and chronic kidney disease progression: a critical review of the evidence. Am J Nephrol 43:281–292CrossRef
Metadata
Title
Fluid intake and chronic kidney disease: effect of coaching an increase in fluid intake on kidney function decline
Authors
Viviana Bozzano
Elena Abati
Gruppo di Autoformazione Metodologica (GrAM)
Publication date
01-12-2018
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 8/2018
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-018-1952-5

Other articles of this Issue 8/2018

Internal and Emergency Medicine 8/2018 Go to the issue

CE - LETTER TO THE EDITOR

A spontaneous rectus sheath hematoma

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.